ÂÜÀòÂÒÂ×

Christopher Bartley is the Director of Operations for Waisman Biomanufacturing. He has a B.S. in Bacteriology from the University of Wisconsin-Madison and has over 20 years of experience in research and product development, including over 15 at WB developing and manufacturing a variety of products including recombinant proteins in CHO, plasmid DNA vaccines in E. coli fermentation systems, gene therapy viral vectors such as AAV, and live microbial therapies (e.g. live attenuated Listeria monocytogenes). He is a subject matter expert in fermentation and bioreactor controls as well as all aspects of downstream processing (chromatography, TFF, filtration). Prior to becoming Director of Operations, Mr. Bartley supervised the bioprocessing group staff involved in development of platform processes and executing contract manufacturing services.